Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry-Reference-Cited by-同舟云学术

Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry

Published:2017-05-19 Issue:31 Volume:8 Page:51416-51428
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Stefanovic Stefan¹²,Wirtz Ralph³,Deutsch Thomas M.²,Hartkopf Andreas⁴,Sinn Peter⁵,Varga Zsuzsanna⁶,Sobottka Bettina⁶,Sotiris Lakis³,Taran Florin-Andrei⁴,Domschke Christoph¹²,Hennigs Andre¹²,Brucker Sara Y.⁷,Sohn Christof¹²,Schuetz Florian¹²,Schneeweiss Andreas¹²,Wallwiener Markus¹²

Affiliation:

1. Department of Gynecology and Obstetrics, Heidelberg University Hospital, 69120 Heidelberg, Germany

2. National Center for Tumor Diseases (NCT) Heidelberg, 69120 Heidelberg, Germany

3. Stratifyer Molecular Pathology GmbH, 50935 Cologne, Germany

4. Department of Women's Health, University Hospital Tübingen, 72076 Tübingen, Germany

5. Department of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany

6. Institute of Surgical Pathology, Zurich University Hospital, 8091 Zurich, Switzerland

7. Research Institute for Women's Health, Tübingen University Hospital, 72076 Tübingen, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation;2023-05-12

2. Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers;Cell Reports Medicine;2023-03

3. Knockdown of CALM2 increases the sensitivity to afatinib in HER2-amplified gastric cancer cells by regulating the Akt/FoxO3a/Puma axis;Toxicology in Vitro;2023-03

4. Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment‐naïve patients: A single‐center study;Cancer Medicine;2022-02-25

5. A Need for More Molecular Profiling in Brain Metastases;Frontiers in Oncology;2022-01-25